May 23, 2013 10:29 PM ET

Biotechnology

Company Overview of Neurotech Pharmaceuticals, Inc.

Company Overview

Neurotech Pharmaceuticals, Inc., a biotechnology company, develops sight-saving therapeutics for chronic retinal diseases in the United States. It offers NT-501, which is used for the treatment of geographic atrophy associated with atrophic age-related macular degeneration and retinitis pigmentosa; encapsulated cell technology platform, which allows sustained delivery of therapeutic factors to the back of the eye; and Neurotech Recovery-Back device that controls and treats back pain using transcutaneous electrical nerve stimulation and neuromuscular electrical stimulation. Neurotech Pharmaceuticals, Inc. was formerly known as Neurotech S.A and changed its name in May 2006. The company was fo...

Detailed Description

701 George Washington Highway

Lincoln, RI 02865

United States

Founded in 1995

Phone:

401-333-3880

Fax:

401-495-2420

www.neurotechusa.com

Key Executives for Neurotech Pharmaceuticals, Inc.

Chief Executive Officer
Age: 59
Chief Financial Officer and Vice President
Age: 57
Chief Scientific Officer and Vice President of Research & Development- USA
Vice President of Business Development
Age: 55
Director of The National Eye Institute and Principal Investigator
Compensation as of Fiscal Year 2012.

Neurotech Pharmaceuticals, Inc. Key Developments

Neurotech Launches Neurotech Recovery-Back
Jul 25 12

Neurotech is introducing the Neurotech Recovery-Back, an innovative and non-invasive device designed to help manage low back pain and rehabilitate the low back and abdominal muscles. Neurotech Recovery-Back device helps control and treat back pain using two clinically proven therapies, TENS (transcutaneous electrical nerve stimulation) and NMES (neuromuscular electrical stimulation). The comfortable and easy-to-wear device integrates two conductive garments that relieve both chronic and acute low back pain. The patient uses a hand-held controller to control the amount of stimulation delivered to the lower back and abdominal muscles. Neurotech Recovery-Back is cleared by the FDA and is only available by prescription.

Neurotech Hires Dominic D'arpino as National Account Manager
Dec 8 11

Neurotech has recently hired Dominic D'Arpino to join its North American team as National Account Manager for the eastern US region. D'Arpino joins Neurotech after working for eight years with Otto Bock HealthCare. While at Otto Bock, he worked as Western Operations Supervisor, Reimbursement Claims Processing Center Manager, Market Manager and Sales Specialist.

Neurotech Pharmaceuticals, Inc. Presents at BIO China International Conference, Oct-12-2011 03:30 PM
Sep 28 11

Neurotech Pharmaceuticals, Inc. Presents at BIO China International Conference, Oct-12-2011 03:30 PM. Venue: Pudong Shangri-La Hotel, 33 Fu Cheng Rd., Pudong, Shanghai 200120, China.

Similar Private Companies By Industry

Company Name Region
Stryker Biotech LLC United States
Cardeus Pharmaceuticals, Inc. United States
RC Fuels, Inc. United States
MGI Pharma Biologics, Inc. United States
Dermal Sciences, Inc. United States

Recent Private Companies Transactions

Type
Date		 Target
Private Placement
August 27, 2012 		--
Private Placement
May 30, 2012 		--
Report Data IssueReport Data Issue
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Neurotech Pharmaceuticals, Inc., please visit www.neurotechusa.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.

Close